14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Dec 11, 2023 Buy 31 000 Hsu Jason Common Stock
Dec 08, 2023 Buy 25 000 Hsu Jason Common Stock
Sep 15, 2023 Buy 7 000 Hsu Jason Common Stock
Sep 14, 2023 Buy 10 000 Hsu Jason Common Stock
Sep 14, 2023 Buy 10 000 Ng Carey Common Stock
Sep 12, 2023 Buy 30 000 Hsu Jason Common Stock
Sep 12, 2023 Buy 13 000 Adams Helen C. Common Stock
Sep 11, 2023 Buy 25 000 Hsu Jason Common Stock
Sep 08, 2023 Buy 10 000 Hsu Jason Common Stock
Sep 07, 2023 Buy 20 000 Buchan Melissa Jane Common Stock
Sep 06, 2023 Buy 9 000 Marquet Magda Common Stock
Sep 05, 2023 Buy 10 000 Marquet Magda Common Stock
Aug 31, 2023 Buy 1 000 Marquet Magda Common Stock
Aug 22, 2023 Buy 20 000 Chudnovsky Yekaterina Stock Option (Right to Buy)
Aug 22, 2023 Buy 16 670 Chudnovsky Yekaterina Stock Option (Right to Buy)
Aug 22, 2023 Buy 0 Chudnovsky Yekaterina Common Stock
Aug 22, 2023 Buy 1 913 661 Chudnovsky Yekaterina Pre-Funded Common Stock Purchase Warrant
Aug 14, 2023 Buy 293 000 Morris Gabriel S Stock Options
Aug 14, 2023 Buy 293 000 Rachman Ilya M Stock Options
Aug 11, 2023 Buy 20 000 Buchan Melissa Jane Stock Options
Aug 11, 2023 Buy 193 000 Morris Gabriel S Stock Options
Aug 11, 2023 Buy 193 000 Rachman Ilya M Stock Options
Aug 11, 2023 Buy 20 000 Ng Carey Stock Options
Aug 11, 2023 Buy 20 000 Adams Helen C. Stock Options
Aug 11, 2023 Buy 20 000 Hsu Jason Stock Options
Aug 11, 2023 Buy 20 000 Marquet Magda Stock Options
Nov 14, 2022 Buy 150 Rachman Ilya M Common Stock
Nov 14, 2022 Buy 1 000 Rachman Ilya M Common Stock
Nov 14, 2022 Buy 4 050 Rachman Ilya M Common Stock
Nov 14, 2022 Buy 5 200 Morris Gabriel S Common Stock
Jul 14, 2022 Sell 200 Senn Sean Common Stock
Jul 14, 2022 Sell 200 Senn Sean Common Stock
Jul 14, 2022 Buy 16 000 Adams Helen C. Stock Options
Jul 14, 2022 Buy 16 000 Marquet Magda Stock Options
Jul 14, 2022 Buy 16 000 Marquet Magda Stock Options
Jul 14, 2022 Buy 250 000 Rachman Ilya M Stock Options
Jul 14, 2022 Buy 16 000 Ng Carey Stock Options
Jul 14, 2022 Buy 16 000 Buchan Melissa Jane Stock Options
Jul 14, 2022 Buy 16 000 Hsu Jason Stock Options
Jul 14, 2022 Buy 250 000 Morris Gabriel S Stock Options
Dec 20, 2021 Buy 2 500 Rachman Ilya M Common Stock
Dec 20, 2021 Buy 3 915 913 Hsu Jason Common Stock
Dec 20, 2021 Buy 50 000 Hsu Jason Common Stock
Dec 20, 2021 Sell 0 Hsu Jason Convertible Note
Dec 20, 2021 Buy 3 000 Torchilin Vladimir P Common Stock
Dec 20, 2021 Buy 123 176 Morris Gabriel S Common Stock
Dec 20, 2021 Buy 123 527 Morris Gabriel S Common Stock
Dec 20, 2021 Buy 2 000 Morris Gabriel S Common Stock
Dec 20, 2021 Buy 74 116 Morris Gabriel S Common Stock
Dec 20, 2021 Sell 0 Morris Gabriel S Convertible Note
Dec 20, 2021 Buy 25 000 Ng Carey Common Stock
Dec 20, 2021 Buy 1 000 221 Ng Carey Common Stock
Dec 20, 2021 Sell 0 Ng Carey Convertible Note
Dec 17, 2021 Buy 2 200 Torchilin Vladimir P Common Stock
Dec 15, 2021 Buy 0 Senn Sean Common stock
Dec 15, 2021 Buy 30 000 Buchan Melissa Jane Options (right to purchase)
Dec 15, 2021 Buy 0 Torchilin Vladimir P Common stock
Dec 15, 2021 Buy 0 Rachman Ilya M Common stock
Dec 15, 2021 Buy 270 000 Rachman Ilya M Options (right to purchase)
Dec 15, 2021 Buy 0 Hsu Jason Common stock
Dec 15, 2021 Buy 0 Hsu Jason Convertible Note
Dec 15, 2021 Buy 256 500 Morris Gabriel S Options (right to purchase)
Dec 15, 2021 Buy 210 000 Morris Gabriel S Options (right to purchase)
Dec 15, 2021 Buy 0 Morris Gabriel S Convertible Note
Dec 15, 2021 Buy 0 Morris Gabriel S Convertible Note
Dec 15, 2021 Buy 37 500 Adams Helen C. Options (right to purchase)
Dec 15, 2021 Buy 60 000 Marquet Magda Options (right to purchase)
Dec 15, 2021 Buy 15 000 Ross Graham Options (right to purchase)
Dec 15, 2021 Buy 0 Ng Carey Convertible Note
Apr 02, 2021 Buy 60 000 Morris Gabriel S Warrants (right to purchase)
INSIDER POWER
80.102
Last 70 transactions
Buy: 10 090 384 | Sell: 400 (Shares)

Based on the 70 latest insides trades, we have calculated the insider power to be positive at a ratio of 80.102.

In total, the insiders bought 10 090 384 and sold 400 IMMX shares in the last 70 trades.

Click to get the best stock tips daily for free!

About Immix Biopharma, Inc.

Immix Biopharma. Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the tr... IMMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT